Elicit: Efficacy of SGLT Activators on Water Absorption (public)
Efficacy of SGLT Activators on Water Absorption
How effective are sodium-glucose cotransport activators in improving water absorption?
Sodium-glucose cotransport activators effectively improve water absorption in both experimental models and human subjects, with amino acid-based and glucose-based formulations showing significant increases in water uptake rates.
Abstract
Sodium‐glucose cotransport activators improve water absorption in both experimental models and human subjects. Many studies report that amino acid–based activators—most notably L‐alanine and leucine—increase water uptake, with one study noting a rise from 17.4 to 43.9 μL/min/g (p < 0.001). Glucose‐based formulations administered in carefully balanced oral rehydration solutions yield similarly positive results; for example, one report documented an increase of 98.6 ± 16 μL/min/g (p < 0.01), and glucose polymers increased absorption rates from 221–240 to 291–332 μL/min/g (p < 0.02 to p < 0.005). In addition, interventions such as stevia extract yielded a 1.8‐fold boost in SGLT1‐mediated glucose transport (p < 0.05), an effect linked to improved water uptake. In diarrheal or secretory models, these activators also lower net fluid secretion and reduce stool water content. Overall, the studies indicate that activators targeting the sodium‐glucose cotransport mechanism effectively enhance water absorption as measured by both quantitative fluid uptake and associated transporter activity.
Methods
We analyzed 29 sources from an initial pool of 997, using 7 screening criteria. Each paper was reviewed for 5 key aspects that mattered most to the research question.
Papers identified with Elicit search
n = 997
Papers screened using: SGLT Activators/Enhancers, Water Absorption Outcome, In Vivo Studies, Appropriate Study Design, SGLT Activators vs Inhibitors, Beyond In Vitro Only, Publication Quality
n = 997
Papers screened out
n = 968
Papers included for extraction
n = 29
Characteristics of Included Studies
| Study | Study Design | Clinical Condition | Intervention Type | Primary Outcome Measure | Full text retrieved |
|---|---|---|---|---|---|
| Wapnir et al., 1988 | Animal experimental study | Osmotic diarrhea (rats) | L-alanine, protein hydrolysate in oral hydration solution | Water and sodium absorption | No |
| Rongione et al., 2001 | Animal experimental; in vivo physiological | Normal dogs | EGF, TGF | Sodium, chloride, water, glucose absorption | No |
| Grahammer et al., 2006 | Animal experimental; in vivo physiological | Normal and dexamethasone-treated mice | Dexamethasone | SGLT1/NHE3 activity, sodium absorption | No |
| Aguero et al., 1990 | Animal experimental; in vivo physiological | Normal and diarrheic Wistar rats | Glutamine in oral rehydration solution | Sodium and water absorption | No |
| ... | ... | ... | ... | ... | ... |
Results
Water Absorption Outcomes
| Study | Activator Type | Water Absorption Effect | Effect Size | Statistical Significance |
|---|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate | Increased water absorption | “Very significant increase” | No mention found |
| Rongione et al., 2001 | EGF, TGF | Increased water absorption | Not quantified | Significant vs. mixed meal (no further details in abstract) |
| Grahammer et al., 2006 | Dexamethasone | No mention found | N/A | N/A |
| Aguero et al., 1990 | Glutamine | Increased water absorption | Not quantified | Not significant (p>0.05) |
| ... | ... | ... | ... | ... |
Sodium Absorption Outcomes
| Study | Activator Type | Sodium Absorption Effect | Effect Size | Statistical Significance |
|---|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate | Increased sodium absorption | “Very significant increase” | No mention found |
| Rongione et al., 2001 | EGF, TGF | Increased sodium absorption | Not quantified | Significant (no further details in abstract) |
| Grahammer et al., 2006 | Dexamethasone | Increased SGLT1/NHE3 activity | Approximately 3x increase (wild type) | Significant (no further details in abstract) |
| Aguero et al., 1990 | Glutamine | Increased sodium absorption | 300% increase | p>0.05 |
| ... | ... | ... | ... | ... |
Comparative Effectiveness of Different Activators
| Study | Activator(s) Compared | Relative Effectiveness | Notes |
|---|---|---|---|
| Wapnir et al., 1988; Wapnir, (Enhancement by Alanine) | L-alanine, protein hydrolysate, glycine | Alanine/protein hydrolysate > glycine (no effect) | Alanine/protein hydrolysate most effective at higher sodium |
| Aguero et al., 1990 | Glutamine vs. control | Glutamine increased sodium absorption 300% | Both normal and diarrheic rats |
| ... | ... | ... | ... |
Context-Dependent Effects and Generalizability
- Animal versus human studies:
- Most evidence is from animal models, limiting direct translation to human clinical settings.
- Disease models:
- The magnitude of effect was often greater in diarrheal or secretory models (such as cholera, rotavirus, Escherichia coli) than in healthy controls.
- Optimal glucose:sodium ratio:
- Optimal composition was reported as critical for maximizing absorption in several studies.
- Hormonal modulation:
- Hormones (aldosterone, Angiotensin II) and drugs (tacrolimus, Teduglutide) were reported to modulate SGLT1 activity.
- Mechanistic insights:
- SGLT1 was the central transporter in most studies.
References
- J. Turner, David E. Cohen, R. Mrsny, J. Madara (2000). Noninvasive In vivo Analysis of Human Small Intestinal Paracellular Absorption: Regulation by Na+-Glucose Cotransport. Digestive Diseases and Sciences.
- Rong Lin et al. (2011). D-glucose acts via sodium/glucose cotransporter 1 to increase NHE3 in mouse jejunal brush border by a Na+/H+ exchange regulatory factor 2-dependent process. Gastroenterology.
- ...